Clinical applications

IMMray™ technology has been developed with the aim to respond to unmet clinical needs. IMMray™ has already shown its applicability within two main disease areas – oncology (pancreatic cancer) and autoimmune diseases with the main focus on Systemic Lupus Erythematosus (SLE).